Haitham Abdelhakim is an Oncology physician affiliated with The University of Kansas Cancer Center. OpenAlex indexes 103 publications with 539 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2330 Shawnee Mission Pkwy Ste 210
Ku Cancer Center, Mailstop 5003
Westwood, KS 662052005
Telephone
913-588-0348Provider last certified this registry record 23 Apr 2024.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
30.1%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor30.1%Acyclovir100%Part D≥17 patientsAnti-infectives
28%Short-acting sulfonamides28%Sulfamethoxazole-Trimethoprim100%Part D<11 patientsCardiovascular
26.9%Statin10.8%Rosuvastatin Calcium100%Part D<11 patientsBeta blocker9.7%Carvedilol100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Delayed fatal neurotoxicity in post CAR-T cell therapy for multiple myeloma, a case report
Leukemia Research Reports
2026 - Impact of Measurable Residual Disease Status on Outcomes After HLA-Matched Donor Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
Clinical Lymphoma Myeloma & Leukemia
2025 - Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated myelodysplastic syndrome: A systematic review and meta-analysis
Critical Reviews in Oncology/Hematology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Weijing Sun, MD
The University of Kansas Cancer Center
Joaquina Baranda, MD
The University of Kansas Cancer Center
Andrea Jewell, MD
The University of Kansas Cancer Center
Marc Hoffmann, MD
The University of Kansas Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”